Warfarin
Warfarin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Active Ulcerative Colitis。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
10 项
已进入 III/IV 期
31 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Hoffmann-La Roche
- Odense University Hospital
- Novo Nordisk A/S
- Joon Bum Kim
- Population Health Research Institute
- GUALTIERO PALARETI
- Guangdong Provincial People's Hospital
- Shanghai Zhongshan Hospital
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
丹麦、美国、South Korea、澳大利亚、加拿大、德国、意大利、中国、Israel、芬兰、瑞典、Nepal
正在招募患者的 Warfarin 研究
Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)
IV 期招募中丹麦NCT06401616A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
I 期招募中美国NCT07710768Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement
IV 期招募中South KoreaNCT04258488The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
III 期招募中澳大利亚加拿大德国NCT04284839START-Register: Survey on Anticoagulated Patients Register
不适用招募中意大利NCT02219984Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
不适用招募中中国NCT07441382Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
不适用招募中中国NCT07677410Determinants of Warfarin Metabolism
不适用招募中IsraelNCT00162474Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial
IV 期招募中中国NCT07349875Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation
不适用招募中芬兰瑞典NCT06696079Vitamin K for Perioperative Warfarin Management
IV 期招募中美国NCT07515664Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
I 期招募中中国NCT07128888Anticoagulation in Post MI LV Thrombus Trial in Nepal
IV 期招募中NepalNCT05794399Rivaroxaban in Idiopathic Membranous Nephropathy
IV 期招募中中国NCT07404436MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis
不适用招募中EgyptJordanMoroccoPakistanNCT07548346A Study on Abnormal Menstrual Bleeding in Chinese Women of Childbearing Age Taking Antithrombotic Drugs After Cardiovascular Surgery
不适用招募中中国NCT07870941Low INR to Minimize Bleeding With Mechanical Valves Trial
III 期招募中比利时BotswanaBrazilCameroonNCT03636295Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease
不适用招募中德国NCT05204212DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
不适用招募中美国奥地利芬兰德国NCT05701917An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
I 期招募中美国比利时德国PolandNCT07665723Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
不适用招募中美国NCT02318342Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device
IV 期招募中美国NCT06655376Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
不适用招募中美国NCT06075628Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement
IV 期招募中日本South KoreaNCT07431762
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。